Skip Navigation

Cardiovascular Research 2001 49(4):882-890; doi:10.1016/S0008-6363(00)00287-X
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mostafa Mtairag, E.
Right arrow Articles by Feldman, L. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mostafa Mtairag, E.
Right arrow Articles by Feldman, L. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion

El Mostafa Mtairaga,c, Sylvie Chollet-Martinb, Mounia Oudghiric, Nathalie Laquaya, Marie-Paule Jacoba, Jean-Baptiste Michela and Laurent J. Feldmana,*

aU460 INSERM, X. Bichat School of Medicine, Paris, France
bImmunology Department and U479 INSERM, Bichat Hospital, Paris, France
cHassan II University, School of Sciences Ain chok, Department of Biology, Casablanca, Morocco

* Corresponding author. Tel.: +33-1-4485-6160; fax: +33-1-4485-6157 laurent.feldman{at}bch.ap-hop-paris.fr

Objective: Monocyte adhesion to endothelial cells and subsequent secretion of matrix metalloproteinases (MMPs) by activated macrophages are key events in arteriosclerosis and restenosis. We tested the hypothesis that interleukin-10 (IL-10), a potent anti-inflammatory cytokine, inhibits monocyte-endothelial cell interactions. Methods: The effect of IL-10 on monocyte/endothelial cell adhesion, as well as on the expression of MMP-9 and the tissue inhibitor of MMP-9, TIMP-1, were first tested in vitro in coculture systems. In addition, we used an ex vivo binding assay to study the inhibitory effect of IL-10 on monocyte adhesion to carotid arteries obtained from either normal, or L-nitro arginine-methyl ester (L-NAME)-treated rats. The effect of IL-10 on the expression of monocyte adhesion molecules (CD18 and CD62-L) was studied by flow cytometry. Results: IL-10 (150 ng/ml) inhibits monocyte adhesion to endothelial cells (by 35%) and to carotid arteries (by 40 and 50%, in normal and L-NAME-treated rats, respectively), via direct modulation of the expression of CD18 and CD62-L. Moreover, IL-10 dose-dependently decreases MMP-9 activity and increases TIMP-1 levels in coculture systems, both at the transcriptional level. Conclusions: Our results suggest that IL-10 is an important modulator of monocyte–endothelial cell interactions.

KEYWORDS Atherosclerosis; Cell culture/isolation; Cytokines; Leukocytes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
C. Stumpf, K. Seybold, S. Petzi, G. Wasmeier, D. Raaz, A. Yilmaz, T. Anger, W. G. Daniel, and C. D. Garlichs
Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction
Eur J Heart Fail, August 1, 2008; 10(8): 733 - 739.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. B Jones, D. C Sane, and D. M Herrington
Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome
Cardiovasc Res, October 1, 2003; 59(4): 812 - 823.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.